IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.836
EU - Europa 4.636
AS - Asia 3.076
SA - Sud America 490
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 24
OC - Oceania 5
Totale 32.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.782
UA - Ucraina 1.361
CN - Cina 1.135
SG - Singapore 1.086
IT - Italia 742
DE - Germania 677
SE - Svezia 641
TR - Turchia 474
BR - Brasile 448
RU - Federazione Russa 345
IE - Irlanda 272
FI - Finlandia 211
VN - Vietnam 162
GB - Regno Unito 142
HK - Hong Kong 63
NL - Olanda 54
IN - India 42
FR - Francia 41
BE - Belgio 34
AT - Austria 33
CA - Canada 33
EU - Europa 25
KR - Corea 23
CZ - Repubblica Ceca 18
AR - Argentina 17
PL - Polonia 15
MX - Messico 14
BD - Bangladesh 12
RS - Serbia 11
AE - Emirati Arabi Uniti 9
IR - Iran 9
PE - Perù 8
UZ - Uzbekistan 8
PH - Filippine 7
CO - Colombia 6
ES - Italia 5
HU - Ungheria 5
MA - Marocco 5
PK - Pakistan 5
AO - Angola 4
IQ - Iraq 4
JP - Giappone 4
LV - Lettonia 4
RO - Romania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
EC - Ecuador 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GH - Ghana 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
MM - Myanmar 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 32.093
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.348
Houston 2.246
Ann Arbor 1.932
Ashburn 1.612
Seattle 1.466
Chandler 1.364
Wilmington 1.309
Cambridge 1.302
Dearborn 815
Jacksonville 685
Beijing 508
Izmir 453
Singapore 436
Boardman 431
Princeton 299
Dublin 269
Udine 189
San Diego 175
Des Moines 163
Dong Ket 158
Falls Church 94
Andover 74
Norwalk 64
Hong Kong 60
Hefei 59
Nanjing 55
Milan 54
Ogden 51
Munich 48
Kunming 39
Guangzhou 38
São Paulo 38
Brussels 34
New York 32
Redmond 32
Shanghai 32
Grafing 30
Los Angeles 30
Jinan 28
Nuremberg 27
Phoenix 27
Fuzhou 26
Rome 23
Trieste 22
Fremont 20
Redwood City 18
Rio de Janeiro 18
Nanchang 17
Venezia 17
Brno 16
Zhengzhou 16
Turin 15
Vienna 15
Belo Horizonte 14
Helsinki 14
Naples 14
Wuhan 14
Bologna 13
Dallas 13
Frankfurt am Main 13
London 13
Maserada Sul Piave 13
Warsaw 13
Council Bluffs 12
Hanover 12
Hebei 12
Washington 12
Düsseldorf 11
Lauterbourg 11
Ottawa 11
Toronto 11
Buenos Aires 10
Changsha 10
Istanbul 10
Santa Clara 10
Shenyang 10
Shenzhen 10
Brescia 9
Taizhou 9
Genoa 8
Indiana 8
Palermo 8
Seoul 8
Sezze 8
Stockholm 8
Tappahannock 8
Campinas 7
Chongqing 7
Jiaxing 7
Lappeenranta 7
San Francisco 7
Simi Valley 7
Turku 7
Boston 6
Chengdu 6
Curitiba 6
Dhaka 6
Grugliasco 6
Tashkent 6
Totale 24.440
Salva come PNG Salva come JPEG
Nome #
Terapia e profilassi delle infezioni 233
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 228
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 222
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 218
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 202
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 199
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 199
The management of multidrug-resistant enterobacteriaceae 191
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 172
Delafloxacin for the treatment of respiratory and skin infections 171
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 162
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 158
Hot topics in necrotising skin and soft tissue infections 158
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 156
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 155
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 154
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 151
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 148
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 147
New therapeutic options for respiratory tract infections 147
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 146
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 144
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 144
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 144
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 143
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 143
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 142
Safety of long-term use of linezolid: Results of an open-label study 142
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 142
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 142
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 141
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 141
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 141
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 140
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 140
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 139
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 139
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 138
The role of dalbavancin in skin and soft tissue infections 138
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 138
Impact of new treatment options for hepatitis c virus infection in liver transplantation 138
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 137
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 137
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 137
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 136
Linezolid underexposure in a patient co-treated with venlafaxine 135
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 135
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 135
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 135
Development of novel antibacterial drugs to combat multiple resistant organisms 135
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 135
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 135
Advances in antibiotic therapy in the critically ill 134
New therapeutic options for skin and soft tissue infections 134
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 134
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 134
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 133
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 133
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 133
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 132
Current and future therapies for invasive aspergillosis 132
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 132
Prosthetic joints: Shining lights on challenging blind spots 132
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 131
Ceftolozane/tazobactam: place in therapy 131
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 131
Are prophylactic antifungals in highly colonized patients safe and effective? 131
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 130
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 130
Is there a future for tigecycline? 130
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 130
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 129
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 129
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 129
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 129
Overview of Fungal Infections - The Italian Experience 129
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 128
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 127
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 127
New antibiotics for bad bugs: Where are we? 127
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 127
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria 126
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study 126
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study 125
Schistosomiasis screening of travelers from italy with possible exposure in Corsica, France 125
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 125
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 125
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 125
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 125
Current antibiotic management of prosthetic joint infections in Italy: the 'Udine strategy'. 124
Safety profiles of old and new antimicrobials for the treatment of MRSA infections 124
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections 124
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies 124
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 124
Ten old antibiotics that will never disappear 124
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site 124
The current treatment landscape: Candidiasis 123
SDD and colistin resistance: End of a dream? 123
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: Focus on staphylococcus aureus 123
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 123
Totale 14.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020438 0 0 0 0 0 0 0 0 0 0 0 438
2020/20215.163 164 589 236 592 341 663 329 524 523 246 474 482
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20253.546 137 357 226 220 138 259 221 354 565 405 457 207
Totale 33.317